HMGB1 and Sepsis: In the LPS/GalN model of sepsis, RvD1 administration significantly reduced high mobility group box-1 (HMGB1), TNF-, IL-6 and macrophage chemotactic protein – 1 (MCP-1) in parallel to a decreased neutrophil recruitment.